Anti-human GFRA3 monoclonal antibody, nadecnemab biosimilar (REGN5069)

Home/ Products / Biosimilar Antibodies

PRODUCT

  • SKU

    DMS1079-100ug

  • Size

    100 ug

  • Price

    $350

1
This monoclonal antibody is part of a collection of biosimilar antibodies in reference to those approved or in clinical investigation. The biosimilars are for Research Use Only and should not be used in therapeutic or diagnostic procedures in humans or animals.
target GFRA3
alias GDNFR3
gene id Uniprote ID: O60609
host species Human
reactivity Human
iso type IgG4
formulation Lyophilized from sterile PBS, pH 7.4. Typically, 5% - 8% trehalose is added as a protective agent prior to lyophilization.
reconstitution Reconstitute lyophilized powder with water to a concentration of 100 ug/ml, solubilize at RT for 30 minutes with occasional gentle tapping. It is recommended that 0.1% HSA be added as a carrier protein for long-term storage.
applications ELISA; Flow Cytometry
dilution ELISA 1:5000-10000; Flow Cyt 1:100
shipping Shipped at ambient conditions.
storage Lyophilized form is stable for 1 week at room temperature. Store at -20 °C to -80 °C for 12 months in lyophilized form. After reconstitution, store at 4 °C for 2-7 days or at below -20 °C for up to 3 months.
note Other commonly used names in publications refering to this antibody: REGN5069

Images

Flow cytometry analysis of 1 ug/mL anti-GFRA3 (nadecnemab biosimilar) mAb on Expi293 cells transfected with Human GFRA3 protein (Blue histogram) or Expi293 transfected with irrelevant protein (Red histogram).

ELISA plate coated with 2 ug/mL (100 uL/well) Human GFRA3 Protein, His Tag binds to anti-GFRA3 neutralizing antibody in a linear range of 2.44?156.25 ng/mL.


PRODUCT

  • SKU

    DMS1079-100ug

  • Size

    100 ug

  • Price

    $350

1